1-1 of 1
Keywords: Epirubicin therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Delayed High-Dose Intravesical Epirubicin Therapy of Superficial Bladder Cancer: A Way to Reduce the Side Effects and Increase the Efficacy – A Phase 2 Trial

Available to Purchase
Subject Area:
Further Areas
PierFrancesco Bassi, Renato Spinadin, Fabrizio Longo, Salim Saraeb, Giovanni Luigi Pappagallo, Filiberto Zattoni, Francesco Pagano
Journal: Urologia Internationalis
Urol Int (2002) 68 (4): 216–219.
https://doi.org/10.1159/000058438
Published Online: 31 May 2002
... reported: unfortunately the dose increase also increased the frequency and the intensity of treatment-related side effects. Materials and Methods: A phase 2 trial was designed to evaluate the toxicity and the activity of a delayed (biweekly) high-dose (80 mg) epirubicin therapy of superficial bladder...
View article titled, Delayed High-Dose Intravesical Epirubicin Therapy of Superficial Bladder Cancer: A Way to Reduce the Side Effects and Increase the Efficacy – A Phase 2 Trial
Open the PDF for Delayed High-Dose Intravesical Epirubicin Therapy of Superficial Bladder Cancer: A Way to Reduce the Side Effects and Increase the Efficacy – A Phase 2 Trial in another window